Support non-clinical immunogenicity studies of sars-COV-2 microneedle patch vaccines candidates in a small-animal model
Ended Awarded Last action
- Contract number
- 75A50122F61001
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $756,111
Award facts
- Opportunity
-
- RTORBIOAMT1026 Solicitation number
- Contract value 100% obligated
- $756,111.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $461,185 | |
| Original award | $294,926 |
About this award
This is a cost-plus-fixed-fee delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Lovelace Biomedical Research Institute, a non-profit preclinical contract research organization. The $756,111 award supports non-clinical immunogenicity studies of SARS-CoV-2 microneedle patch vaccine candidates in a small-animal model. This work is being performed under ASPR's Biological Animal Model Development 2017-2022 IDIQ contract. Lovelace Biomedical Research Institute has supported numerous federal agencies through both contracts and grants, leveraging its expertise in animal modeling and preclinical product development across areas like infectious diseases, drug discovery, and medical countermeasures. The award does not utilize a set-aside designation.
Quick answers
Who was awarded contract 75A50122F61001?
75A50122F61001 was awarded to Lovelace Biomedical Research Institute by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on March 8, 2022.
How much is contract 75A50122F61001 worth?
The government has obligated $756,111 on 75A50122F61001.
Is contract 75A50122F61001 an order under another contract?
Yes. 75A50122F61001 is a delivery order under HHSO100201700023I, an indefinite delivery contract, on BARDA Biological Animal Model Development 2017-2022.
Was contract 75A50122F61001 competed?
The extent of competition for 75A50122F61001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award